Neurology® Podcast

SPECIAL REPORT on Aducanumab Approval: Steve Pearson of ICER Discusses the Economic and Clinical Impact

31 min • 17 juni 2021

Dr. Jason Crowell speaks with Dr. Steve Pearson, President of the Institute for Clinical and Economic Review, about the clinical and economic impact of aducanumab, a drug recently approved by the FDA for the treatment of Alzheimer disease.

Senaste avsnitt

Podcastbild

00:00 -00:00
00:00 -00:00